New Key Statistics Module, Z-Score and F-Score
OTCPK:CLVLY Key Ratios
Market Cap $ M | 489.07 |
Enterprise Value $ M | 377.10 |
P/E(ttm) | 25.41 |
PE Ratio without NRI | 25.41 |
Forward PE Ratio | 18.52 |
Price/Book | 4.24 |
Price/Sales | 9.89 |
Price/Free Cash Flow | 21.89 |
Price/Owner Earnings | 25.25 |
Payout Ratio % | 0.09 |
Revenue (TTM) $ M | 54.00 |
EPS (TTM) $ | 0.38 |
Beneish M-Score | -2.33 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 31.20 |
y-y EBITDA Growth Rate % | 11.50 |
EV-to-EBIT | 11.31 |
EV-to-EBITDA | 11.09 |
PEG | 0.81 |
Shares Outstanding M | 50.13 |
Net Margin (%) | 37.12 |
Operating Margin % | 53.20 |
Pre-tax Margin (%) | 56.37 |
Quick Ratio | 6.43 |
Current Ratio | 6.86 |
ROA % (ttm) | 15.99 |
ROE % (ttm) | 18.75 |
ROIC % (ttm) | 107.56 |
Dividend Yield % | 0.33 |
Altman Z-Score | 16.92 |
CLVLY Number of Guru Trades
CLVLY Volume of Guru Trades
Gurus Latest Trades with OTCPK:CLVLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CLVLY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Clinuvel Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:CLVLY
Total 0- 1